Imbruvica (Ibrutinib) 140mg x 120 Tablets

Imbruvica is an oral medication that contains the active ingredient Ibrutinib, a targeted therapy used primarily for the treatment of certain types of blood cancers, including chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL). It works by inhibiting a specific protein that promotes cancer cell growth, thereby helping to slow down or stop the progression of the disease.

Indications

Imbruvica is indicated for the treatment of:

• Chronic Lymphocytic Leukemia (CLL)
• Mantle Cell Lymphoma (MCL)
• Waldenström's Macroglobulinemia
• Chronic Graft-versus-Host Disease (cGVHD)

Dosage and Administration

The recommended dosage of Imbruvica is 140mg taken orally once daily. It is important to take the medication at the same time each day, with or without food. Patients should follow their healthcare provider's instructions regarding dosage adjustments and duration of treatment.

Side Effects

Common side effects of Imbruvica may include:

• Diarrhea
• Fatigue
• Nausea
• Muscle and joint pain
• Increased risk of infections

Patients should report any severe or persistent side effects to their healthcare provider.

Precautions

Before starting Imbruvica, patients should inform their healthcare provider of any pre-existing conditions, especially:

• Heart problems
• Liver disease
• History of bleeding disorders

Imbruvica may interact with other medications, so it is essential to discuss all current medications with a healthcare provider.

Storage

Store Imbruvica at room temperature, away from moisture and heat. Keep out of reach of children and pets.

Conclusion

Imbruvica (Ibrutinib) offers an effective treatment option for patients with specific types of blood cancers. With proper medical guidance, it can help manage symptoms and improve quality of life.